CORONAVIRUS/WHO selects Taiwan's Medigen COVID-19 vaccine for international trial
10/26/2021 10:46 PM
Taipei, Oct. 26 (CNA) A COVID-19 vaccine developed by Taiwan's Medigen Vaccine Biologics Corp. has been chosen to take part in an international clinical trial platform co-launched by the World Health Organization (WHO), according to a statement released by the organization Tuesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in CORONAVIRUS
- Taiwan to roll out updated Moderna COVID vaccine starting Sept. 26Taiwan will roll out Moderna's COVID-19 vaccine against the Omicron subvariant XBB starting Sept. 26, according to Centers for Disease Control (CDC) Director General Chuang ...09/20/2023 06:29 PM
- Taiwan to roll out updated Moderna COVID vaccine by late September: CDCTaiwan plans to roll out Moderna's COVID-19 vaccine against the Omicron subvariant XBB.1.5 before the Sept. 29- Oct. 1 Mid-Autumn Festival holiday weekend, the Centers for ...09/19/2023 06:32 PM
- Taiwan grants EUA for updated Moderna COVID vaccineTaiwan's Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for Moderna's Spikevax XBB.1.5 COVID-19 vaccine and is planning to roll out the new jab ...09/13/2023 09:40 PM
Latest
- Society
Taiwan headline news
09/22/2023 10:14 AM - Business
U.S. dollar up in Taipei trading
09/22/2023 10:12 AM - Business
Taiwan shares open lower
09/22/2023 09:10 AM - Politics
Most 'America skepticism' discourse in Taiwan originates locally: researcher
09/21/2023 11:40 PM - Politics
Cabinet passes draft to tighten security at military facilities
09/21/2023 11:28 PM